Pfizer drug Xalkori effective in treating non-small cell lung cancer

September 28, 2014 7:02 AM

9 0

Pfizer drug Xalkori effective in treating non-small cell lung cancer

A new clinical trial, presented at medical meeting on Saturday, has strongly shown that medicine maker Pfizer Inc’s lung cancer drug Xalkori can do wonders in treating people with an even rarer form of the disease.

The drug Xalkori can help in treating patients of lung cancer with a specific gene mutation.

Read more

To category page

Loading...